Maple M Fung1, Kuixing Zhang, Lian Zhang, Fangwen Rao, Daniel T O'Connor. 1. Department of Medicine, Institute for Genomic Medicine, University of California at San Diego, VA San Diego Healthcare System, La Jolla, California 92093-0838, USA. mafung@ucsd.edu
Abstract
PURPOSE OF REVIEW: Essential hypertension has long been considered to be primarily 'genetic,' though recent studies have only revealed minor contributions to blood pressure. Technology has advanced tremendously in the recent years, with much focus on DNA studies utilizing both candidate gene and genome-wide association studies. However, many new areas that need continued investigation have arisen. RECENT FINDINGS: In addition to DNA studies, genetic studies are actively pursuing previously unexplored areas of potential variation, such as that which occurs posttranscriptionally in RNA and posttranslationally in protein structure. Advances have also been made in animal models and systems biology for large-scale integrative approaches. However, many other areas need continued investigation in the genetics of hypertension, including improved phenotyping and trait definition, gene-by-gene interactions (epistasis), and gene-by-environment interactions. 'Next generation' sequencing will assist researchers in performing more extensive genetic studies even more quickly, especially on unusual (rare) genetic variants. SUMMARY: Hypertension appears to have many genetic contributions from each regulatory area ranging from DNA to RNA to protein to postprotein to interactive influences of the environment on genes. New technologies have enabled such research to advance in the recent years. However, for this complex trait of hypertension, continued efforts must progress in all of these areas as well as in increased modeling and sequencing, so that the knowledge may be united for a comprehensive understanding of this common disease, such that diagnosis and treatment options in hypertensive patients and those at risk are facilitated.
PURPOSE OF REVIEW: Essential hypertension has long been considered to be primarily 'genetic,' though recent studies have only revealed minor contributions to blood pressure. Technology has advanced tremendously in the recent years, with much focus on DNA studies utilizing both candidate gene and genome-wide association studies. However, many new areas that need continued investigation have arisen. RECENT FINDINGS: In addition to DNA studies, genetic studies are actively pursuing previously unexplored areas of potential variation, such as that which occurs posttranscriptionally in RNA and posttranslationally in protein structure. Advances have also been made in animal models and systems biology for large-scale integrative approaches. However, many other areas need continued investigation in the genetics of hypertension, including improved phenotyping and trait definition, gene-by-gene interactions (epistasis), and gene-by-environment interactions. 'Next generation' sequencing will assist researchers in performing more extensive genetic studies even more quickly, especially on unusual (rare) genetic variants. SUMMARY:Hypertension appears to have many genetic contributions from each regulatory area ranging from DNA to RNA to protein to postprotein to interactive influences of the environment on genes. New technologies have enabled such research to advance in the recent years. However, for this complex trait of hypertension, continued efforts must progress in all of these areas as well as in increased modeling and sequencing, so that the knowledge may be united for a comprehensive understanding of this common disease, such that diagnosis and treatment options in hypertensivepatients and those at risk are facilitated.
Authors: Jacquelyn Y Taylor; Aldi T Kraja; Lisa de Las Fuentes; Ansley Grimes Stanfill; Ashley Clark; Ann Cashion Journal: J Nurs Scholarsh Date: 2013-01-31 Impact factor: 3.176
Authors: Christina M Pettey; Jean C McSweeney; Katharine E Stewart; Elvin T Price; Mario A Cleves; Seongkum Heo; Elaine Souder Journal: Eur J Cardiovasc Nurs Date: 2014-10-16 Impact factor: 3.908
Authors: Alfred Kongnyu Njamnshi; Michel Karngong Mengnjo; Eta Ngole Mbong; Samuel Kingue; Julius Yundze Fonsah; Andreas Ateke Njoh; Leonard Njamnshi Nfor; Leonard Ngarka; Samuel Eric Chokote; Felicien Enyime Ntone Journal: BMC Cardiovasc Disord Date: 2017-05-08 Impact factor: 2.298